Treatment of autoimmune and inflammatory diseases with epratuzumab

Details for Australian Patent Application No. 2010294905 (hide)

Owner UCB Pharma, S.A.

Inventors Novotney-Barry, Anna-Marie; Hulhoven, Reginald; Parker, Gerald L.; Hoskin, Violet A.

Agent Griffith Hack

Pub. Number AU-A-2010294905

PCT Pub. Number WO2011/032633

Priority 61/243,797 18.09.09 US

Filing date 26 August 2010

Wipo publication date 24 March 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

5 April 2012 PCT application entered the National Phase

  PCT publication WO2011/032633 Priority application(s): WO2011/032633

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010294914-Method and device for generating partial views and/or a stereoscopic image master from a 2D-view for stereoscopic playback

2010294901-Ink jet printable etching inks and associated process